tolvaptan has been researched along with Abdominal Aortic Aneurysm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chang, WH; Lu, HY; Shih, CC; Wu, TC | 1 |
SoRelle, R | 1 |
2 other study(ies) available for tolvaptan and Abdominal Aortic Aneurysm
Article | Year |
---|---|
Tolvaptan reduces angiotensin II-induced experimental abdominal aortic aneurysm and dissection.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Disease Models, Animal; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Knockout, ApoE; Tolvaptan | 2022 |
Rofecoxib use increases acute myocardial infarction risk.
Topics: Aortic Aneurysm, Abdominal; Benzazepines; Cardiology; Cholesterol; Female; Heart Failure; Humans; Lactones; Male; Myocardial Infarction; Seasons; Sulfones; Tolvaptan | 2004 |